Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, SE5 8AF, United Kingdom.
Centre of Mathematics, Computation, and Cognition, Universidade Federal do ABC, Rua Arcturus, Jardim Antares, São Bernardo do Campo, SP CEP 09.606-070, Brazil.
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):58-75. doi: 10.1016/j.neubiorev.2017.01.002. Epub 2017 Jan 10.
Deep learning (DL) is a family of machine learning methods that has gained considerable attention in the scientific community, breaking benchmark records in areas such as speech and visual recognition. DL differs from conventional machine learning methods by virtue of its ability to learn the optimal representation from the raw data through consecutive nonlinear transformations, achieving increasingly higher levels of abstraction and complexity. Given its ability to detect abstract and complex patterns, DL has been applied in neuroimaging studies of psychiatric and neurological disorders, which are characterised by subtle and diffuse alterations. Here we introduce the underlying concepts of DL and review studies that have used this approach to classify brain-based disorders. The results of these studies indicate that DL could be a powerful tool in the current search for biomarkers of psychiatric and neurologic disease. We conclude our review by discussing the main promises and challenges of using DL to elucidate brain-based disorders, as well as possible directions for future research.
深度学习(DL)是机器学习方法的一个分支,在科学界受到了广泛关注,在语音和视觉识别等领域打破了基准记录。DL 与传统的机器学习方法不同,它能够通过连续的非线性变换从原始数据中学习最优表示,从而实现越来越高的抽象和复杂性水平。鉴于其检测抽象和复杂模式的能力,DL 已被应用于精神和神经疾病的神经影像学研究中,这些疾病的特征是细微和弥散的改变。在这里,我们介绍了 DL 的基本概念,并回顾了使用这种方法对基于大脑的疾病进行分类的研究。这些研究的结果表明,DL 可能是当前寻找精神和神经疾病生物标志物的有力工具。最后,我们讨论了使用 DL 阐明基于大脑的疾病的主要优势和挑战,以及未来研究的可能方向。